Drug intelligence / Profile preview

G-CSF + GM-CSF

Development stage
Unknown
Lead developer
Partner Therapeutics
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous
01

Overview

G-CSF + GM-CSF is a combination of two hematopoietic growth factors that stimulate the production and function of white blood cells. G-CSF primarily stimulates neutrophil production and release from bone marrow, while GM-CSF affects multiple cell lineages including granulocytes, macrophages, and dendritic cells. The combination has been investigated for various applications including: - Mobilization of peripheral blood progenitor cells (PBPCs) for collection by leukapheresis - Accelerating hematopoietic recovery after high-dose chemotherapy and stem cell transplantation - Enhancing immune responses in cancer immunotherapy - Improving antibody-dependent cellular cytotoxicity (ADCC) in treatments like dinutuximab for neuroblastoma Studies have shown that sequential or combined administration of these cytokines may provide superior mobilization of hematopoietic progenitor cells compared to either agent alone.

Brand names
NeupogenLeukine
Other names
Granulocyte Colony-Stimulating Factor + Granulocyte-Macrophage Colony-Stimulating FactorColony-Stimulating Factor 3 + Granulocyte-Macrophage Colony-Stimulating Factor
02

Targets

CSF2R (Granulocyte-macrophage colony-stimulating factor receptor)CSF3R (Granulocyte colony-stimulating factor receptor)

Beyond the preview

Go deeper on G-CSF + GM-CSF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G-CSF + GM-CSF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call